Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by biodelatechon Jun 24, 2010 12:47am
447 Views
Post# 17216916

Not so serious

Not so serious
The Fda says:
This meeting has been cancelled to allow time for the
resolution of several outstanding issues. The agency intends to continue
evaluating NDA 22340 and, as needed, may schedule an advisory committee meeting
in the future.
https://www.federalregister.gov/OFRUpload/OFRData/2010-15352_PI.pdf
What does it mean?
If they the issues another meeting will be scheduled.
There's nothing sinister about that.
Maybe fast-track has been too fast for Lux to get everything right.
If there were major flaws the FDA could have simply rejected the NDA .
But the FDA simply grants more time for the resolution of issues.
That has happened many times before.
<< Previous
Bullboard Posts
Next >>